Regulatory DNA design
Generate and optimize enhancers, promoters, transcription-factor response elements, and noncoding regulatory regions for target activity and reduced off-target signal.
We translate biological objectives into multi-objective computational design campaigns—generating, optimizing, and ranking DNA and RNA candidates for focused experimental testing.
Each engagement is scoped around a biological objective, an explicit design space, a set of predictive constraints, and a practical experimental handoff.
Generate and optimize enhancers, promoters, transcription-factor response elements, and noncoding regulatory regions for target activity and reduced off-target signal.
Design synthetic introns and splice-regulatory elements with target donor/acceptor usage, cell-context specificity, and explicit cryptic-splice risk analysis.
Optimize 5′/3′ UTR architecture, microRNA response elements, sequence composition, and post-transcriptional control logic for context-dependent expression.
Build computational generation and filter cascades for guide, array, tracrRNA, and broader locus architectures, with sequence-quality and structural plausibility checks.
Coordinate enhancer, promoter, intron, and UTR design as a staged program so that several regulatory layers contribute complementary selectivity.
Translate a research brief into a documented Proto program, select appropriate generators and constraints, run design sweeps, and deliver an auditable analysis package.
The program is designed around explicit trade-offs rather than a single prediction score. That makes the rationale, failure modes, and candidate selection criteria easier to inspect.
Define target and off-target contexts, mutable regions, fixed sequence context, success criteria, assay plan, and synthesis constraints.
Map each sequence region to generators and constraints, select optimization stages, and establish positive, negative, and baseline controls.
Run broad candidate generation followed by focused refinement using rejection sampling, MCMC, gradient-based search, or beam search where appropriate.
Evaluate model agreement, sequence diversity, genomic or plasmid context robustness, motif liabilities, cryptic splice sites, and single-mutation sensitivity.
Provide ranked sequences, per-constraint scorecards, design rationale, reproducible code or program files, and a recommended experimental panel.
Every candidate is accompanied by the context needed to decide what to synthesize, what to test, and what could fail.
These examples are reported in the Proto preprint and are shown as evidence of platform capability—not as client results from this independent service concept.
AlphaGenome and SpliceTransformer constraints were combined with MCMC optimization across multiple sequence contexts. Sixty-five candidates were screened, with hits recovered in three of four design directions.
Evo 2 generation, promoter-strength and motif constraints, rejection sampling, and MCMC refinement produced diverse promoters with preserved σ70 grammar. Seventy-one of 86 exceeded the activity of PLtetO1 in the reported assay.
A published NSCLC-focused program coordinated several regulatory layers. Reported predictions included approximately 9× higher H3K27ac for the enhancer and 7.1× higher miRNA-mediated repression in healthy lung than A549 for the off-switch.
Interpretation: computational scores prioritize candidates and reduce search space; they do not guarantee biological function. Experimental validation remains essential.
Scopes below are intentionally modular and can be adapted to a single sequence element or a coordinated regulatory system.
Determine whether the objective is computable with available models and define a credible campaign architecture.
Generate, optimize, stress-test, and rank a focused DNA or RNA candidate library.
Coordinate multiple sequence elements and regulatory layers around a shared functional objective.
A target function, the sequence region that may change, fixed flanking context, target and off-target biological contexts, preferred assay, sequence length limits, and any synthesis or IP constraints.
This landing page is structured around computational design and analysis. Wet-lab work can be scoped through a qualified partner, but computational predictions should never be presented as experimentally confirmed results.
Yes. Local mutation and MCMC-style refinement are often appropriate when preserving most of an existing construct is important. De novo or autoregressive generation is more suitable when broader novelty is acceptable.
By separating optimization models from hold-out evaluation where possible, testing multiple sequence contexts, examining each constraint independently, retaining sequence diversity, and flagging cases in which predictors disagree.
No. This is an independent service concept built around publicly available Proto workflows. Any commercial page should retain a clear non-affiliation statement unless a formal relationship exists.
Submit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk